Women’s Excellence, an obstetric and gynecologic office in Michigan, is offering a new service for women who are experiencing infertility due to endometriosis. The condition, caused by the growth of endometrial tissue outside the uterus, often leads to the development of nodules or lesions.
Endometriosis patients commonly report pelvic pain (75 percent of cases) and fertility problems affect as many as 50 percent of all patients, according to the National Institutes of Health. Women with the disease may experience painful and debilitating menstrual cramps, and pain during intercourse.
The Women’s Excellence treatment plan is comprehensive and personalized, aiming to alleviate disease-related pain at all stages in a women’s life while also also helping those who want to have children to become pregnant.
“Endometriosis is a very complicated disease process that needs a well thought out treatment plan which encompasses a woman’s desire for future fertility, likelihood of problems in menopause, emotional aspects of the potential for loss of feminine organs, pelvic symptomatology and the impact to her life. The specialists at Women’s Excellence in Endometriosis look at all of these factors and then comprehensively develops a customized treatment plan for every woman which may vary depending on the specific characteristics of each woman and their individual needs and desires,”Dr. Jonathan Zaidan, president of Women’s Excellence, said in a press release.
In addition to endometriosis, Women’s Excellence also offers specialized treatment for problems relating to in menopause, weight control, and bladder control, and its services include robotic surgery, pelvic floor physical therapy, and midwifery.
A study, titled “Uterine Leukocyte Function and Dysfunction: A Hypothesis on the Impact of Endometriosis,” explored the impact of leukocytes in the uterus and their role in endometriosis, and may lead to new treatments for the disease. In the study, published in the journal American Journal of Reproductive Immunology, Michigan State University researchers reviewed the difference between two types of immune cells, the uterine natural killer cells (NK cells are the predominant leukocyte population in the normal human endometrium) and regulatory T-cells within the eutopic endometrium between patients with endometriosis and healthy controls.